Metabolic acidosis is a frequent and potentially serious medical condition that occurs when the body produces too much acid or when the kidneys are not able to effectively remove acid from the body. Non-anion gap metabolic acidosis (NAGMA) is a specific type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. This type of acidosis is typically caused by a variety of medical conditions, such as kidney failure, certain medications, and certain genetic disorders. In this article, we will explore the causes and treatment options for NAGMA. We will discuss the various medical conditions that can cause NAGMA, the medications that can contribute to this condition, and the genetic disorders that can lead to NAGMA. We will also discuss the various treatments available for NAGMA, including lifestyle changes, medications, and other treatments.
Non-anion gap metabolic acidosis (NAGMA) is a type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. This type of acidosis is typically caused by a variety of medical conditions, such as kidney failure, certain medications, and certain genetic disorders. NAGMA is a type of metabolic acidosis that is characterized by an abnormally high level of acid in the blood. The acidity of the blood is measured using the anion gap, which is the difference between the concentrations of the two main types of electrolytes in the blood: anions and cations. In NAGMA, the anion gap is normal, meaning that the levels of anions and cations are equal.
What Causes Non-Anion Gap Metabolic Acidosis?
NAGMA is typically caused by a variety of medical conditions, medications, and genetic disorders. The most common causes of NAGMA include:
Kidney Failure
Kidney failure is one of the most common causes of NAGMA. When the kidneys are not functioning properly, they are unable to filter out the acids that are produced in the body, leading to an accumulation of acid in the blood.
Medications
Certain medications, such as diuretics and antifungal medications, can also cause NAGMA. These medications can interfere with the body’s ability to filter out acids, leading to an accumulation of acid in the blood.
Genetic Disorders
Certain genetic disorders, such as inherited metabolic disorders, can also lead to NAGMA. These disorders can interfere with the body’s ability to process and eliminate acids, leading to an accumulation of acid in the blood.
The treatment of NAGMA depends on the underlying cause of the condition. In some cases, lifestyle changes may be enough to reduce the acid levels in the blood. In other cases, medications may be needed to reduce the acid levels in the blood. In some cases, other treatments, such as dialysis, may be necessary.
Non-anion gap metabolic acidosis (NAGMA) is a type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. NAGMA is typically caused by a variety of medical conditions, medications, and genetic disorders. The treatment of NAGMA depends on the underlying cause of the condition, and may include lifestyle changes, medications, and other treatments.
1.
Why breast cancer survivors don't take their medicine, and what can be done about it.
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
FDA Approves New Drug Combo for RR Multiple Myeloma
4.
Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches
2.
HCC Codes in Oncology: Care Optimization in Plexiform Neurofibroma Management
3.
Understanding Mantle Cell Lymphoma Prognosis.
4.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
5.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
4.
Navigating the Complexities of Ph Negative ALL - Part VIII
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation